Bielski R, Bose A, Chang CC. A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder. Annals of Clinical Psychiatry 2005; 17(2): 65-69.
Guest J, Russ J, Lenox-Smith A. Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom. European Journal of Health Economics 2005; 6(2): 136-145.
Heuzenroeder L, Donnelly M, Haby M, et al. Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Australia and New Zealand Journal of Psychiatry 2004; 38(8): 602-612.
Issakidis C, Sanderson K, Corry J, et al. Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders. Psychological Medicine 2004; 34(1): 19-35.
Wan G, Zhang H, Tedeschi M, et al. Estimation of symptom-free days in generalized anxiety disorder. Current Medical Research and Opinion 2006; 22(3): 587-591.